← All trials

NCT06268964

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Sep 1, 2024
Primary completion
Dec 31, 2024
Completion date
Jun 30, 2025
First posted
Feb 21, 2024
Last posted
Aug 16, 2024
Enrollment
82
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.